•  
  •  
  •  
  •  

2025-09-01 21:38:08

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp dispatches 5.54 lakh Motorcycles and Scooters in August 2025
  • InfoBeans Technologies Ltd wins Asia's Best Employer Brand Award from World HRD Congress
  • Websol Energy System Ltd approves expansion of manufacturing capacity
  • CEAT acquires Michelin Group's CAMSO Construction Compact Line Business
  • BCML collaborates with CIPET Ahmedabad to bring 'Bioyug on Wheels'

Keywords Selected:  SCI

Research

  • Bayer Cropscience - Q1FY23 Result Update - Good set of numbers in challenging scenario - Accumulate
  • Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY
  • Krishna Institute of Medical Sciences - Management Meet Update - Stepping up - BUY
  • Solara Active Pharma Sciences - Recovering business provides respite - ICICI Securities
  • IPO Review - Supriya Lifescience Ltd - ICICI Direct
  • Supriya Lifescience - IPO - Strong R&D Focused API Player - Reliance Research

IPO News

  • Kronox Lab Sciences IPO subscribed 117.25 times on Final Day
  • Kronox Lab Sciences IPO fully subscribed in less than half an hour of opening
  • Kronox Lab Sciences Limited raises Rs. 39.04 crore from Anchor Investors
  • Kronox Lab Sciences Ltd's Initial Public Offering to open on Friday June 3, 2024
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Kronox Lab Sciences Limited files DRHP for IPO
  • Rockingdeals IPO opens today, Anchor Book fully subscribed
  • Rockingdeals IPO price band announced at Rs. 136-Rs. 140 per share, issue opens on November 22
  • Rockingdeals Circular Economy Ltd files DRHP with NSE Emerge for IPO
  • Shilpa Pharma Lifesciences Ltd to file for IPO

Stock Report

  • Sai Life Sciences completes Phase II of Production Block 11 at Bidar, India, expands capacity to 700 KL
  • Nutricircle Ltd enters into Distribution Agreement with Barentz Distribution India Pvt Ltd
  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide Facility at Hyderabad, India
  • Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio, Princeton, NJ, U.S. to Accelerate ADC Innovation
  • Insecticides India Ltd partners with Corteva Agriscience to Launch 'SPARCLE' - A Revolutionary Insecticide for Paddy Farmers
  • Nectar Lifesciences Ltd's Unit VI gets CGMP certification from SMDC
  • Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
  • Yatharth Hospitals to be included in the prestigious MSCI India Small Cap Index
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 & 1 mg
  • Bayer CropScience Limited reports Q1 Results for FY 2025-26
  • Krishna Institute of Medical Sciences Ltd Q1 FY26 consolidated profit drops to Rs. 78.6 crores
  • Zydus announces completion of the acquisition of an 85.6% stake in Amplitude Surgical
  • Eiko Lifesciences Ltd consolidated Q1FY26 net profit at Rs. 1.11 crore
  • Strides Pharma Science Ltd consolidated Q1FY26 profit at Rs. 99.60 crores
  • Cohance Lifesciences Appoints Yann D'Herve as CEO of CDMO Business, Effective August 1, 2025
  • Astec LifeSciences Ltd consolidated Q1FY26 loss at Rs. 33.03 crores
  • RPG Life Sciences Ltd Q1 FY2026 PAT slips to Rs. 26.29 crores
  • Solara Active Pharma Sciences Ltd consolidated Q1FY26 PAT rises to Rs. 10.52 crores
  • Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
  • Clean Science and Technology Ltd consolidated Q1FY26 PAT at Rs. 70.06 crores
  • Closure of Remote Regulatory Assessment by the USFDA at Matoda, Gujarat facility

Industry News

  • Conscious Chemist announces INR 12 Cr funding from Atomic Capital, welcomes Apoorv Gautam to the Board

Latest Post

  • Hero MotoCorp dispatches 5.54 lakh Motorcycles and Scooters in August 2025
  • InfoBeans Technologies Ltd wins Asia's Best Employer Brand Award from World HRD Congress
  • Websol Energy System Ltd approves expansion of manufacturing capacity
  • CEAT acquires Michelin Group's CAMSO Construction Compact Line Business
  • BCML collaborates with CIPET Ahmedabad to bring 'Bioyug on Wheels'


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024